EMEA-002981-PIP01-21 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Other
PIP number: P/0504/2021
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-000727-PIP01-09-M07 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Oncology
PIP number: P/0336/2023
Route(s) of administration: Oral use
Pharmaceutical form(s):
Capsule (hard)
Film-coated tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-001821-PIP01-15-M06 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Oncology
PIP number: P/0091/2023
Route(s) of administration: Oral use
Pharmaceutical form(s):
Film-coated tablet
Powder for oral solution
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-002063-PIP01-16-M02 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Pneumology-allergology
PIP number: P/0068/2023
Route(s) of administration: Inhalation use
Pharmaceutical form(s):
Pressurised inhalation
Suspension
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-002070-PIP01-16-M07 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Neurology
PIP number: P/0086/2023
Route(s) of administration: Oral use
Pharmaceutical form(s):
Powder for oral solution
Film-coated tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-002079-PIP01-16-M03 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Uro-nephrology
PIP number: P/0070/2023
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-003170-PIP01-21-M01 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Endocrinology-Gynaecology-Fertility-Metabolism
PIP number: P/0100/2023
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-000334-PIP01-08-M11 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Pain
PIP number: P/0080/2023
Route(s) of administration: Inhalation use
Pharmaceutical form(s):
Inhalation vapour (liquid)
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-000576-PIP01-09-M14 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Immunology-Rheumatology-Transplantation
PIP number: P/0102/2023
Route(s) of administration: Oral use
Pharmaceutical form(s):
Film-coated tablet
Prolonged-release film-coated tablet
Oral solution
Prolonged-release age-appropriate oral formulation
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-000997-PIP01-10-M06 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Other
PIP number: P/0088/2023
Route(s) of administration: Oral use
Pharmaceutical form(s):
Film-coated tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman